The Board of Certification in Anesthesiology (BCA) credential validates advanced competency in anesthesia practice for CRNAs, anesthesiologists, and anesthesiology assistants seeking formal recognition of their clinical knowledge. Whether you're preparing for initial board certification or a recertification cycle, passing the BCA exam requires mastery of anesthesia pharmacology, patient assessment, airway management, monitoring standards, and post-anesthesia care — all under timed exam conditions.

This free BCA practice test PDF gives you printable questions across the full spectrum of anesthesiology board content so you can study on your own schedule. PDF preparation is especially effective for high-stakes board exams because it forces active recall — no autocomplete, no instant feedback — which produces stronger long-term retention than passive review of notes or slides.

CRNAs (Certified Registered Nurse Anesthetists), physician anesthesiologists preparing for board review, and anesthesiology assistants (AAs) all benefit from structured PDF practice. The BCA exam tests both theoretical knowledge and clinical decision-making, so your preparation should cover both the science behind anesthetic agents and the judgment calls you make in the OR.

The BCA exam rewards clinicians who understand not just what anesthetic agents do, but why — the pharmacokinetic and pharmacodynamic principles that determine onset, duration, and recovery. Here's a comprehensive look at the major content areas.

Anesthesia Physiology: Cardiovascular and Respiratory Effects

Every anesthetic agent affects the cardiovascular and respiratory systems — understanding these effects and how to manage them is foundational BCA content. Inhalation agents cause dose-dependent myocardial depression and vasodilation, reducing systemic vascular resistance and mean arterial pressure. The cardiovascular depression is most pronounced with halothane (now rarely used), moderate with isoflurane and sevoflurane, and least with desflurane. Desflurane is notable for causing sympathetic activation (tachycardia, hypertension) with rapid increases in concentration — this limits its use for induction.

All inhalation agents cause dose-dependent respiratory depression, increasing PaCO2 and decreasing tidal volume and respiratory rate. Hypoxic pulmonary vasoconstriction (HPV) — the normal mechanism that redirects blood away from poorly ventilated lung segments — is inhibited by inhalation agents, which can worsen V/Q mismatch during one-lung ventilation. IV induction agents also depress respiration; propofol apnea is common at induction doses and requires backup ventilation support.

Inhalation Anesthetic Agents

Sevoflurane is the most commonly used agent for inhalation induction because of its non-pungent odor and rapid rise in alveolar concentration (MAC = 2.0%). It undergoes some hepatic metabolism to fluoride and compound A (potentially nephrotoxic at very low flow rates, though clinical significance is debated). Recovery is rapid due to low blood-gas solubility (0.65).

Desflurane has the lowest blood-gas solubility (0.42) of clinical agents, producing the fastest emergence — particularly valuable for lengthy surgeries. Its pungency precludes inhalation induction. It requires a specialized heated vaporizer (Tec 6 or equivalent) because of its near-room-temperature boiling point. The sympathomimetic response with rapid concentration increases must be managed.

Isoflurane remains a cost-effective agent with a blood-gas solubility of 1.4 and MAC of 1.2%. It provides excellent skeletal muscle relaxation and is a potent coronary vasodilator. Concerns about coronary steal syndrome in patients with fixed coronary lesions have been largely refuted in clinical practice. It is extensively used in developing countries due to its low cost.

Nitrous oxide (N2O) is an inorganic gas with low potency (MAC = 104%) — it cannot produce general anesthesia alone at atmospheric pressure. It is used as a carrier gas to provide analgesia and reduce requirements for other agents (second gas effect). N2O diffuses into air-containing cavities (pneumothorax, bowel, middle ear, air emboli) and is contraindicated when such expansion is dangerous. It inhibits methionine synthase with prolonged use, potentially causing megaloblastic anemia and neurological toxicity.

IV Induction Agents

Propofol (2,6-diisopropylphenol) is the most widely used IV induction agent. Its rapid onset (30–60 seconds), short duration of action, and antiemetic properties make it ideal for outpatient procedures and TIVA (total IV anesthesia). Propofol infusion syndrome (PRIS) — metabolic acidosis, rhabdomyolysis, and cardiac failure — is a rare but potentially fatal complication of prolonged high-dose infusions, more common in critically ill patients. Propofol causes significant hypotension via vasodilation and negative inotropy — a hazard in hypovolemic patients.

Etomidate is distinguished by its hemodynamic stability, making it the agent of choice for hemodynamically compromised patients and rapid sequence induction in trauma. Its mechanism involves GABAergic potentiation. The major limitation is adrenocortical suppression — a single induction dose suppresses cortisol production for 4–8 hours via 11-β hydroxylase inhibition. This is particularly relevant in septic shock patients. Myoclonus on induction is common.

Ketamine is a dissociative anesthetic that works via NMDA receptor antagonism. Unlike other induction agents, it stimulates the sympathetic nervous system — increasing heart rate, blood pressure, and cardiac output — making it valuable in hypovolemic patients. It provides profound analgesia, making it useful for painful procedures in emergency settings. Contraindications include elevated intracranial pressure, open globe injuries, and uncontrolled hypertension. Emergence phenomena (vivid dreams, hallucinations) are common in adults and are attenuated by concurrent benzodiazepine administration.

Muscle Relaxants and Reversal

Succinylcholine remains the gold standard for rapid sequence intubation (RSI) because of its ultrashort onset (60 seconds) and short duration (~10 minutes). It is a depolarizing agent that causes initial fasciculations followed by flaccid paralysis via sustained ACh receptor activation. Key side effects: hyperkalemia (dangerous in burns, crush injuries, denervation injuries, prolonged immobility — can cause cardiac arrest), masseter spasm, malignant hyperthermia triggering, and elevated intraocular and intragastric pressure.

Rocuronium is a non-depolarizing aminosteroid agent. At high doses (1.2 mg/kg), its onset approaches succinylcholine, making it acceptable for RSI when succinylcholine is contraindicated. Its duration is dose-dependent (intermediate at standard doses). The availability of sugammadex — which specifically encapsulates rocuronium (and vecuronium) for rapid reversal — has made rocuronium increasingly preferred for RSI in many institutions.

Traditional reversal of non-depolarizing block uses neostigmine (anticholinesterase) combined with an anticholinergic (glycopyrrolate or atropine) to prevent muscarinic side effects. Neostigmine reversal should occur only when there is evidence of spontaneous recovery (TOF ratio ≥0.1). Sugammadex provides faster and more complete reversal independent of block depth, without cardiovascular side effects.

Opioid Analgesics in Anesthesia

Opioids remain central to balanced anesthesia despite interest in opioid-free techniques. Fentanyl (100× morphine potency) is the most commonly used intraoperative opioid. Remifentanil is unique for its ester hydrolysis by tissue esterases — context-sensitive half-life is constant regardless of infusion duration, making it ideal for TIVA but requiring transition analgesia before emergence. Morphine and hydromorphone are used for longer-acting postoperative analgesia; morphine's histamine release is clinically relevant in susceptible patients. All opioids cause dose-dependent respiratory depression, bradycardia, nausea, and ileus.

Airway Management and the Difficult Airway

The ASA Difficult Airway Algorithm (DAA) is a mandatory knowledge area. The DAA distinguishes between anticipated and unanticipated difficult airways and provides decision trees for awake vs. asleep intubation, video laryngoscopy, supraglottic airway use, and the "cannot intubate, cannot oxygenate" (CICO) emergency requiring cricothyrotomy or surgical airway. Airway assessment tools include the Mallampati classification (I–IV based on pharyngeal structures visible with mouth open), thyromental distance, sternomental distance, neck extension, and interincisor gap. No single predictor is fully reliable — the combination of findings is used to assess overall risk.

Monitoring Standards and Malignant Hyperthermia

ASA Standard Monitoring requires continuous ECG, pulse oximetry (SpO2), non-invasive blood pressure at minimum 5-minute intervals, inspired oxygen concentration (FiO2 alarm), ventilator disconnect alarm, and quantitative expired CO2 (ETCO2). Temperature monitoring is required when temperature changes are intended or anticipated. BIS and processed EEG monitoring is used to guide depth of anesthesia and reduce awareness under anesthesia (AUA) — incidence is approximately 1–2 per 1,000 general anesthetics.

Malignant hyperthermia (MH) is a life-threatening pharmacogenetic disorder triggered by volatile inhalation agents and succinylcholine in susceptible individuals (autosomal dominant RYR1 gene mutations in most cases). Signs include rapid increase in ETCO2 (often the earliest sign), tachycardia, muscle rigidity, hyperthermia, and acidosis. Treatment requires immediate removal of triggering agents, 100% oxygen, and IV dantrolene (2.5 mg/kg, repeat as needed). The MHAUS hotline (1-800-MH-HYPER) provides real-time management guidance. Dantrolene blocks RYR1 calcium release channels, interrupting the hypermetabolic cascade.

Regional Anesthesia Techniques

Spinal anesthesia involves injection of local anesthetic (and often opioid adjuvants) into the subarachnoid space at L3-L4 or L4-L5. Onset is rapid (3–5 minutes), the block is dense and predictable, and the level is controlled by patient positioning and baricity of the solution. Complications include post-dural puncture headache (PDPH — treated with caffeine, hydration, and epidural blood patch in refractory cases), hypotension (from sympathectomy), and rare neurological injury. Epidural anesthesia uses a catheter for continuous dosing — onset is slower (15–20 minutes) but adjustable for duration and intensity. Local anesthetic systemic toxicity (LAST) — presenting as cardiovascular collapse and seizures from intravascular injection or rapid absorption — is managed with immediate lipid emulsion therapy (Intralipid 20%).

Post-Anesthesia Care and PACU

The Aldrete score (modified) assesses PACU recovery across activity, respiration, circulation, consciousness, and oxygen saturation — a score of 9–10 out of 10 is typically required for discharge from PACU. Common PACU complications include postoperative nausea and vomiting (PONV — Apfel score guides prophylaxis), inadequate pain control, respiratory depression (oversedation, residual neuromuscular block, airway obstruction), hypothermia, and hemodynamic instability. PONV prophylaxis uses 5-HT3 antagonists (ondansetron), dexamethasone, scopolamine patches, and antihistamines depending on risk stratification.

Work through the BCA practice test PDF one content domain at a time rather than all at once. Pharmacology and airway management typically account for the largest share of board exam content — prioritize those sections if your study time is limited. After your first pass, score each domain separately and list your weakest areas. Targeted review of specific topics produces better results than re-reading broad outlines.

For interactive online practice by content area, visit the BCA practice tests page — it offers timed scored question sets with answer explanations so you can drill specific topics between PDF sessions.